Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026)

Bausch Health Companies' (BHC) quarterly Income from Non-Controlling Interests came in at $2.0 million in Q2 2026, up 110.0% year-over-year from $952381.0 in Q2 2025, and up 125.0% quarter-over-quarter from -$8.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Income from Non-Controlling Interests across 14 years of filings, most recently posting $2.0 million for Q2 2026.

  • In Q2 2026, Income from Non-Controlling Interests rose 110.0% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $5.0 million (up 110.0% YoY), while the FY2025 annual figure was -$37.0 million, down 42.31% from the prior year.
  • Income from Non-Controlling Interests came in at $2.0 million for Q2 2026 at Bausch Health Companies, up from -$8.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $9.0 million in Q4 2025 to a low of -$28.0 million in Q1 2025.
  • Average Income from Non-Controlling Interests over 5 years is -$4.4 million, with a median of -$4.0 million recorded in 2023.
  • Year-over-year, Income from Non-Controlling Interests soared 200.0% in 2022 and sank 1200.0% in 2024.
  • Over 5 years, Income from Non-Controlling Interests stood at $4.0 million in 2022, then plunged by 300.0% to -$8.0 million in 2023, then surged by 162.5% to $5.0 million in 2024, then jumped by 80.0% to $9.0 million in 2025, then sank by 77.78% to $2.0 million in 2026.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $2.0 million in Q2 2026, -$8.0 million in Q1 2026, and $9.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -918,959.97
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 11.95 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 2.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 -20.00 Mn
Mar 31, 2025 -28.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 -7.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -13.00 Mn
Dec 31, 2023 -8.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 -8.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn